Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

TENET HEALTHCARE CORP
Next earnings Jul 16, 2026 (after close) · consensus $4.22 EPS, $5.48B rev
Last earnings -1.7% on 2026-04-30
Hospital operator trading at 11.1x earnings and 0.7x sales with 56% ROE, surging cash flow and aggressive buybacks — cheap and improving.
Sources: SEC EDGAR (CIK 0000070318, latest 10-Q filed 2026-04-30) · EODHD · analysis by claude-code · as of 6/21/2026, 8:44:29 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The fundamentals carry the rating, but the price is rich (~24% above our fair-value estimate) — a quality-at-a-price call. The case rests on the business, not the entry; patient buyers may wait for a pullback.
Tenet runs hospitals and ambulatory surgery centers, and the FY2025 picture is far better than the optically alarming earnings decline suggests. Net income fell 41.8% to $2.37B and EPS dropped 52.6% to $15.49, but that is versus an FY2024 ($4.06B) that was inflated by one-time gains; the FY2025 result is well above the $1.0B-$1.5B the company earned in FY2021-FY2023. On a normalized basis, profitability is strong: operating margin 16.5%, net margin 11.1%, and an exceptional return on equity of 56.1%.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $19.5B | $19.2B | $20.6B | $20.7B | $21.3B |
| Gross profit | — | — | — | — | — |
| Operating income | $2.87B | $2.33B | $2.51B | $5.96B | $3.51B |
| Net income | $1.48B | $1.00B | $1.31B | $4.06B | $2.37B |
| Diluted EPS | $8.42 | $3.79 | $5.71 | $32.70 | $15.49 |
| Net margin | 7.6% | 5.2% | 6.4% | 19.7% | 11.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1482 tracked peers · median
1 buy · 3 sells · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 0 open-market buys · 6 sales
| 2026-05-28 | KERREY J ROBERT Director | Sell | 1.97K @ $173.12 | $341K |
| 2026-05-28 | KERREY J ROBERT Director | Sell | 1.69K @ $173.97 | $294K |
| 2026-05-28 | KERREY J ROBERT Director | Sell | 713.00 @ $175.13 | $125K |
| 2026-05-28 | KERREY J ROBERT Director | Sell | 905.00 @ $176.89 | $160K |
| 2026-05-28 | KERREY J ROBERT Director | Sell | 361.00 @ $177.52 | $64.1K |
| 2026-05-27 | West Nadja Director | Sell | 3.00K @ $177.35 | $532K |